| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks
1 company
Fred Burke is See Remarks at GRDN. Fred Burke's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $140.5M at current prices.
Historically, Fred Burke's trades have earned a below-average insider score of 14/100 across 3 rated trades. Over a 12-month horizon, none of those trades were profitable, with an average 12-month return of -78.7%.
The GRDN filings lean toward selling, a net 1,557,239 shares.
Fred Burke has 9 Form 4 filings on record from September 2024 to September 2026, all as Guardian Pharmacy Services (GRDN), 2024–2026.
The 10 reported transactions were 4 option exercises, 3 open-market sales, 2 option or other derivative awards and 1 gift.
Counted by filing, the open-market trades come to no purchases and 2 sales worth about $37.8M.
The largest open-market sale was 671,432 shares of GRDN at an average $29.68 on March 20, 2026, about $19.9M.
Neither of the two sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.